| Literature DB >> 29948065 |
Henk Everaars1, Lourens F H J Robbers2,3, Marco Götte2, Pierre Croisille4, Alexander Hirsch5,6, Paul F A Teunissen2, Peter M van de Ven7, Niels van Royen2, Felix Zijlstra5, Jan J Piek8, Albert C van Rossum2,3, Robin Nijveldt2.
Abstract
OBJECTIVES: The aim of the present study was to evaluate the diagnostic performances of strain and wall thickening analysis in discriminating among three types of myocardium after acute myocardial infarction: non-infarcted myocardium, infarcted myocardium without microvascular obstruction (MVO) and infarcted myocardium with MVO.Entities:
Keywords: Left ventricular function; Magnetic resonance Imaging; Myocardial contraction; ST elevation myocardial infarction
Mesh:
Year: 2018 PMID: 29948065 PMCID: PMC6223851 DOI: 10.1007/s00330-018-5493-0
Source DB: PubMed Journal: Eur Radiol ISSN: 0938-7994 Impact factor: 5.315
Fig. 1Example of strain and strain rate analysis in a patient after acute anterior myocardial infarction. Short-axis images (A and B) on identical locations 4 days after acute anterior myocardial infarction. The LGE image (A) demonstrates extensive hyperenhancement and MVO (arrows) of the anterior and anteroseptal wall. The end-systolic tagging image (B) shows limited deformation of the infarct zone (arrows), which is confirmed after strain analysis by a diminished peak circumferential strain (C) and reduced peak systolic and diastolic circumferential strain rates (D). AN = anterior, AS = anteroseptal, IS = inferoseptal, IN = inferior, IL = inferolateral, AL = anterolateral, MVO = microvascular obstruction
Baseline characteristics
| Characteristic | |
|---|---|
| Age (years) | 57 ± 10 |
| Male gender | 57 (80%) |
| Body mass index (kg/m2) | 27 ± 3 |
| Risk factors | |
| Family history of CAD | 32 (45%) |
| Hypertension | 17 (24%) |
| Hypercholesterolemia | 9 (13%) |
| Diabetes mellitus | 24 (34%) |
| Smoking | 57 (80%) |
| Maximum CK-MB (U/l) | 212 ± 224 |
| Time to reperfusion (h) | 2.4 [1.5-3.6] |
| TIMI flow grade 3 post PCI | 67 (94%) |
| GP IIb/IIIa inhibitor used | 24 (34%) |
| Infarct related artery | |
| LAD | 45 (63%) |
| LCx | 6 (8%) |
| RCA | 20 (28%) |
| Medication at discharge | |
| ACE inhibitor or ATII antagonist | 65 (92%) |
| Aspirin | 71 (100%) |
| Beta-blocker | 70 (99%) |
| P2Y12 inhibitor | 71 (100%) |
| Statin | 71 (100%) |
| LV volumes and LV function | |
| LV ED volume (ml/m2)* | 93 ± 15 |
| LV ES volume (ml/m2)* | 49 ± 14 |
| LV EF (%) | 49 ± 8 |
| Microvascular obstruction | 37 (52%) |
Data are mean ± standard deviation, absolute number (%) or median [interquartile range]. CAD = coronary artery disease; CK-MB = creatine kinase myocardial band; GP = glycoprotein; ACE = angiotensin-converting enzyme; ATII = angiotensin II receptor; LV ED = left ventricular end-diastolic; LV ES = left ventricular end-systolic; LV EF = left ventricular ejection fraction; * = indexed for body surface area
Segmental function, stratified by presence of hyperenhancement
| Characteristic | Hyperenhanced ( | Non-enhanced ( | |
|---|---|---|---|
| Wall thickening | |||
| absWT (mm) | 1.9 ± 1.7 | 4.0 ± 1.8 | < 0.001 |
| relWT (%) | 27 ± 31 | 65 ± 41 | < 0.001 |
| Circumferential strain | |||
| CS (%) | -6.6 ± 3.8 | -12.7 ± 4.5 | < 0.001 |
| Systolic CSR (%/ms) | -4.6 ± 2.6 | -7.6 ± 3.1 | < 0.001 |
| Diastolic CSR (%/ms) | 5.0 ± 6.1 | 9.1 ± 4.6 | < 0.001 |
| Radial strain | |||
| RS (%) | 7.4 ± 6.5 | 15.6 ± 10.6 | < 0.001 |
| Systolic RSR (%/ms) | 5.8 ± 5.0 | 9.4 ± 5.2 | < 0.001 |
| Diastolic RSR (%/ms) | -6.6 ± 4.0 | -10.7 ± 6.0 | < 0.001 |
Data as mean ± standard deviation. AbsWT= absolute wall thickening; relWT= relative wall thickening; CS = peak circumferential strain; CSR = circumferential strain rate; RS = peak radial strain; RSR = radial strain rate
Fig. 2Receiver-operator characteristic curves of wall thickening and strain. Receiver-operator characteristic (ROC) curves with corresponding area under the curves (AUCs) and 95% confidence intervals of wall thickening (top row), circumferential strain (middle row) and radial strain (bottom row) for detecting hyperenhancement (left column) and microvascular obstruction (right column). AbsWT = absolute wall thickening; relWT = relative wall thickening; CS = peak circumferential strain; CSR = peak circumferential strain rate; RS = peak radial strain; RSR = peak radial strain rate
Deformation of infarcted segments, stratified by presence of MVO
| Characteristic | MVO ( | No MVO ( | Uncorrected | Corrected |
|---|---|---|---|---|
| Wall thickening | ||||
| absWT (mm) | 1.4 ± 1.4 | 2.3 ± 1.7 | < 0.001 | 0.657 |
| relWT (%) | 17 ± 22 | 34 ± 34 | < 0.001 | 0.148 |
| Circumferential strain | ||||
| CS (%) | -5.3 ± 3.4 | -7.6 ± 3.7 | < 0.001 | <0.001 |
| Systolic CSR (%/ms) | -4.0 ± 2.7 | -5.1 ± 2.4 | < 0.001 | <0.001 |
| Diastolic CSR (%/ms) | 4.0 ± 4.2 | 5.8 ± 7.1 | < 0.001 | 0.019 |
| Radial strain | ||||
| RS (%) | 4.9 ± 4.6 | 9.3 ± 7.0 | < 0.001 | 0.152 |
| Systolic RSR (%/ms) | 4.6 ± 4.0 | 6.8 ± 5.5 | < 0.001 | 0.011 |
| Diastolic RSR (%/ms) | -5.4 ± 3.5 | -7.5 ± 4.2 | < 0.001 | 0.024 |
| Transmural extent of infarction (%) | 64.9 [42.3-84.7] | 13.9 [4.7-34.8] | < 0.001 | |
Data as mean ± standard deviation or median [interquartile range]. The far right column displays the p values after correction for transmural extent of infarction. Abbreviations as in Table 2
Fig. 3Relationship between CS and transmural extent of infarction. Scatterplot demonstrating the relationship between CS and transmural extent of infarction in hyperenhanced segments with (red) and without MVO (blue). Abbreviations as in Figs. 1 and 2
Optimal cut-off values and diagnostic performance of strain and wall thickening for detecting hyperenhancement and detecting microvascular injury within hyperenhanced segments
| Characteristic | Hyperenhancement | MVO | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Optimal cut-off | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Accuracy (%) | Optimal cut-off | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | Accuracy (%) | |
|
| ||||||||||||
| absWT | 2.7 mm | 72 | 79 | 68 | 82 | 76 | 2.1 mm | 75 | 61 | 51 | 82 | 65 |
| relWT | 48 % | 81 | 70 | 63 | 86 | 74 | 31 % | 79 | 60 | 51 | 84 | 66 |
|
| ||||||||||||
| CS | -9.6 % | 81 | 76 | 68 | 87 | 78 | -6.2 % | 75 | 74 | 60 | 85 | 74 |
| Systolic CSR | -5.9 %/ms | 72 | 78 | 67 | 82 | 76 | -4.7 %/ms | 71 | 68 | 54 | 82 | 69 |
| Diastolic CSR | 5.5 %/ms | 68 | 84 | 72 | 81 | 77 | 3.5 %/ms | 61 | 77 | 58 | 79 | 71 |
|
| ||||||||||||
| RS | 8.1 % | 68 | 80 | 67 | 80 | 75 | 5.7 % | 68 | 74 | 58 | 81 | 72 |
| Systolic RSR | 5.8 %/ms | 64 | 74 | 61 | 77 | 70 | 5.0 %/ms | 70 | 65 | 51 | 80 | 66 |
| Diastolic RSR | -6.8 %/ms | 63 | 76 | 62 | 77 | 71 | -4.7 %/ms | 50 | 82 | 59 | 75 | 70 |
PPV = positive predictive value; NPV = negative predictive value; other abbreviations as in Table 2 and 3